Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

被引：0

作者：

Mogenet, Alice

Greillier, Laurent

Denicolai, Emilie

Barlesi, Fabrice

Bertucci, Francois

Finetti, Pascal

Tomasini, Pascale

机构：

[1] Aix Marseille Univ, Hop Nord, AP HM, INSERM,CNRS,CRCM,Multidisciplinary Oncol & Therap, Marseille, France

[2] Hop Nord Marseille, Multidisciplinary Oncol & Therapeut Innovat, Marseille, France

[3] Aix Marseille Univ, CNRS, CRCM, INSERM,UMR1068,UMR725,Lab Oncol Predict, Marseille, France

[4] Gustave Roussy & Paris Saclay Univ, Fac Med, Villejuif, France

[5] Inst Paoli Calmettes, Dept Med Oncol, Marseille, France

[6] Hop Nord Marseille, AP HM, Serv Oncol Multidisciplinaire & Innovat Therapeut, Marseille, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e21162

引用

页数：1